EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chronic Kidney Disease as a Comorbidity in Heart Failure

Magdalena Szlagor iD, Jill Dybiec iD, Ewelina Młynarska iD, Jacek Rysz, Beata Franczyk

International Journal of Molecular Sciences · 03.02.2023 · 24 (3) · 2988

DOI: 10.3390/ijms24032988 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2023. Verfasst von Magdalena Szlagor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland. Hauptthemen laut MEDLINE: Heart Failure, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is one of the greatest problems in healthcare and it often coexists with declining renal function. The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterioration. It is also associated with difficulties in the treatment of aggravating HF and chronic kidney disease (CKD) and, as a consequence, recurrent hospitalizations and death. As the worsening of renal function has an undeniably negative impact on the outcomes in patients with HF, searching for new treatment strategies and identification of biomarkers is necessary. This review is focused on the pathomechanisms in chronic kidney disease in patients with HF and therapeutic strategies for co-existing CKD and HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureRenal Insufficiency, ChronicHumansMineralocorticoid Receptor AntagonistsComorbidityAngiotensin Receptor AntagonistsStroke Volume

Stichwörter der Autor:innen

GFRangiotensin receptor–neprilysin inhibitor (ARNI)chronic kidney disease (CKD)ejection fractionfinerenoneheart failure (HF)kidney replacementmineralocorticoid receptor antagonists (MRAs)renin–angiotensin–aldosterone system inhibitors (RAAS-I)sodium–glucose cotransporter 2 inhibitors (SGLT2)uremic toxins

Substanzen

Mineralocorticoid Receptor AntagonistsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
  • Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Żeromskiego 113, 90-549 Łódź, Poland.

ORCID-Profile: Magdalena Szlagor, Jill Dybiec, Ewelina Młynarska

Zitieren

APA

Szlagor, M., Dybiec, J., Młynarska, E., Rysz, J., & Franczyk, B. (2023). Chronic Kidney Disease as a Comorbidity in Heart Failure. International Journal of Molecular Sciences, 24(3), 2988. https://doi.org/10.3390/ijms24032988

Vancouver

Szlagor M, Dybiec J, Młynarska E, Rysz J, Franczyk B. Chronic Kidney Disease as a Comorbidity in Heart Failure. International Journal of Molecular Sciences. 2023;24(3):2988. doi:10.3390/ijms24032988

BibTeX
@article{Szlagor2023,
  author = {Szlagor, Magdalena and Dybiec, Jill and Młynarska, Ewelina and Rysz, Jacek and Franczyk, Beata},
  title = {Chronic Kidney Disease as a Comorbidity in Heart Failure},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2988},
  doi = {10.3390/ijms24032988}
}
Kostenlos starten →